Sancesario GM - Search Results

1

Plasmin system of Alzheimer's disease patients: CSF analysis.

Martorana A, Sancesario GM, Esposito Z, Nuccetelli M, Sorge R, Formosa A, Dinallo V, Bernardi G, Bernardini S, Sancesario G. Martorana A, et al. Among authors: sancesario gm, sancesario g. J Neural Transm (Vienna). 2012 Jul;119(7):763-9. doi: 10.1007/s00702-012-0778-y. Epub 2012 Mar 14. J Neural Transm (Vienna). 2012. PMID: 22415062

2

Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation?

Sancesario GM, Esposito Z, Nuccetelli M, Bernardini S, Sorge R, Martorana A, Federici G, Bernardi G, Sancesario G. Sancesario GM, et al. Among authors: sancesario g. Exp Neurol. 2010 Jun;223(2):371-6. doi: 10.1016/j.expneurol.2009.07.028. Epub 2009 Aug 5. Exp Neurol. 2010. PMID: 19664624

3

Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance.

Kalimutho M, Minutolo A, Grelli S, Formosa A, Sancesario G, Valentini A, Federici G, Bernardini S. Kalimutho M, et al. Cancer Chemother Pharmacol. 2011 Jun;67(6):1299-312. doi: 10.1007/s00280-010-1428-4. Epub 2010 Aug 24. Cancer Chemother Pharmacol. 2011. PMID: 20734047

4

Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis.

Mori F, Rossi S, Sancesario G, Codecà C, Mataluni G, Monteleone F, Buttari F, Kusayanagi H, Castelli M, Motta C, Studer V, Bernardi G, Koch G, Bernardini S, Centonze D. Mori F, et al. Neuropsychopharmacology. 2011 Feb;36(3):559-68. doi: 10.1038/npp.2010.187. Epub 2010 Oct 13. Neuropsychopharmacology. 2011. PMID: 20944553 Free PMC article.

5

Glaucoma progression associated with altered cerebral spinal fluid levels of amyloid beta and tau proteins.

Nucci C, Martucci A, Martorana A, Sancesario GM, Cerulli L. Nucci C, et al. Among authors: sancesario gm. Clin Exp Ophthalmol. 2011 Apr;39(3):279-81. doi: 10.1111/j.1442-9071.2010.02452.x. Clin Exp Ophthalmol. 2011. PMID: 20973903 No abstract available.

6

Salivary miRNAome profiling uncovers epithelial and proliferative miRNAs with differential expression across dentition stages.

Formosa A, Piro MC, Docimo R, Maturo P, Sollecito DR, Kalimutho M, Sancesario G, Barlattani A, Melino G, Candi E, Bernardini S. Formosa A, et al. Cell Cycle. 2011 Oct 1;10(19):3359-68. doi: 10.4161/cc.10.19.17647. Epub 2011 Oct 1. Cell Cycle. 2011. PMID: 21926479

7

Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease.

Monteleone G, Fantini MC, Onali S, Zorzi F, Sancesario G, Bernardini S, Calabrese E, Viti F, Monteleone I, Biancone L, Pallone F. Monteleone G, et al. Mol Ther. 2012 Apr;20(4):870-6. doi: 10.1038/mt.2011.290. Epub 2012 Jan 17. Mol Ther. 2012. PMID: 22252452 Free PMC article. Clinical Trial.

8

Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients.

Martorana A, Esposito Z, Di Lorenzo F, Giacobbe V, Sancesario GM, Bucchi G, Bonnì S, Bernardini S, Sorge R, Sancesario G, Bernardi G, Caltagirone C, Koch G. Martorana A, et al. Among authors: sancesario gm, sancesario g. J Neural Transm (Vienna). 2012 Jul;119(7):771-8. doi: 10.1007/s00702-012-0780-4. Epub 2012 Mar 9. J Neural Transm (Vienna). 2012. PMID: 22402892

9

The load of amyloid-β oligomers is decreased in the cerebrospinal fluid of Alzheimer's disease patients.

Sancesario GM, Cencioni MT, Esposito Z, Borsellino G, Nuccetelli M, Martorana A, Battistini L, Sorge R, Spalletta G, Ferrazzoli D, Bernardi G, Bernardini S, Sancesario G. Sancesario GM, et al. Among authors: sancesario g. J Alzheimers Dis. 2012;31(4):865-78. doi: 10.3233/JAD-2012-120211. J Alzheimers Dis. 2012. PMID: 22717612

10

Frailty among Alzheimer's disease patients.

Koch G, Belli L, Giudice TL, Lorenzo FD, Sancesario GM, Sorge R, Bernardini S, Martorana A. Koch G, et al. Among authors: sancesario gm. CNS Neurol Disord Drug Targets. 2013 Jun;12(4):507-11. doi: 10.2174/1871527311312040010. CNS Neurol Disord Drug Targets. 2013. PMID: 23574166 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters